Forman R G, Demouzon J, Feinstein M C, Testart J, Frydman R
Service de Gynécologie-Obstetrique, INSERM Unité 187, Hopital Antoine Béclère, Clamart, France.
Hum Reprod. 1991 Jan;6(1):113-7. doi: 10.1093/oxfordjournals.humrep.a137243.
The gonadotrophic regulation of folliculogenesis has been extensively investigated but little attention has been paid to the influence of early follicular phase levels of endogenous FSH and the FSH/LH ratio when planning ovulation stimulation therapy for IVF. The influence of these factors was investigated in the three studies reported in this paper. A fixed schedule of ovulation stimulation therapy which employed standard treatment regimens, irrespective of the ovarian response, was used to eliminate variation due to treatment factors. Cycles were pretreated with an oestrogen-progestogen contraceptive pill or a progestogen (norethisterone). It was found that both oestrogen-progestogen and progestogen alone decreased the plasma FSH level, although the FSH/LH ratio was significantly reduced only by oestrogen-progestogens. In clinical IVF studies, oestrogen-progestogen pretreatment was associated with a significant reduction in the preovulatory concentration of oestradiol in plasma and the number of aspirated follicles, compared to norethisterone. The administration of FSH for 2 days following oestrogen-progestogen pretreatment and prior to the fixed schedule of ovulation stimulation normalized ovarian steroidogenesis and follicular development. Early follicular phase supplementation with FSH had no influence on progestogen pretreated cycles. The final experiment investigated the influence of FSH/LH levels in the early follicular phase on the outcome of ovarian stimulation. The preovulatory oestradiol concentration was reduced when baseline FSH/LH levels were low compared with when these values were high. Administration of FSH for 2 days in the early follicular phase improved the preovulatory level of oestradiol when baseline FSH/LH was low but had no effect when baseline FSH/LH levels were high.(ABSTRACT TRUNCATED AT 250 WORDS)
卵泡生成的促性腺激素调节已得到广泛研究,但在为体外受精(IVF)制定排卵刺激治疗方案时,人们对内源性促卵泡激素(FSH)的卵泡早期水平及FSH与促黄体生成素(LH)的比值的影响关注甚少。本文报道的三项研究对这些因素的影响进行了调查。采用固定的排卵刺激治疗方案,该方案采用标准治疗方案,而不考虑卵巢反应,以消除治疗因素引起的差异。周期先用雌激素 - 孕激素避孕药或孕激素(炔诺酮)进行预处理。结果发现,雌激素 - 孕激素和单独使用孕激素均可降低血浆FSH水平,不过只有雌激素 - 孕激素能显著降低FSH/LH比值。在临床IVF研究中,与炔诺酮相比,雌激素 - 孕激素预处理与血浆中排卵前雌二醇浓度及吸出卵泡数量的显著降低有关。在雌激素 - 孕激素预处理后且在固定的排卵刺激方案之前给予FSH 2天,可使卵巢类固醇生成和卵泡发育正常化。卵泡早期补充FSH对孕激素预处理的周期没有影响。最后一项实验研究了卵泡早期FSH/LH水平对卵巢刺激结果的影响。与基线FSH/LH水平高时相比,基线FSH/LH水平低时,排卵前雌二醇浓度降低。当基线FSH/LH水平低时,卵泡早期给予FSH 2天可提高排卵前雌二醇水平,但基线FSH/LH水平高时则无作用。(摘要截选至250字)